Guy-Charles Fanneau de la Horie
Direktor/Vorstandsmitglied bei GENFLOW BIOSCIENCES PLC
Vermögen: 9 861 $ am 30.06.2024
Aktive Positionen von Guy-Charles Fanneau de la Horie
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GENFLOW BIOSCIENCES PLC | Direktor/Vorstandsmitglied | 29.06.2022 | - |
| Independent Dir/Board Member | 29.06.2022 | - | |
| PHARNEXT SCA | Direktor/Vorstandsmitglied | 10.07.2023 | - |
Karriereverlauf von Guy-Charles Fanneau de la Horie
Ehemalige bekannte Positionen von Guy-Charles Fanneau de la Horie
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PHERECYDES PHARMA | Vorstandsvorsitzender | 01.04.2016 | 19.05.2022 |
| NEOVACS | Direktor/Vorstandsmitglied | 22.09.2011 | 17.10.2013 |
| Vorstandsvorsitzender | 11.04.2007 | 17.10.2013 | |
PathoQuest SAS
 PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | Vorstandsvorsitzender | - | - |
| NANOBIOTIX | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Guy-Charles Fanneau de la Horie
| INSEAD | Masters Business Admin |
Statistik
International
| Frankreich | 7 |
| Vereinigtes Königreich | 2 |
Operativ
| Director/Board Member | 4 |
| Chief Executive Officer | 3 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| NEOVACS | Health Technology |
| NANOBIOTIX | Health Technology |
| GENFLOW BIOSCIENCES PLC | Health Technology |
| PHARNEXT SCA | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Pherecydes Pharma SA
 Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Pherecydes Pharma SA is a biotechnology company, which engages in the research and development of anti-infective therapies based on the use of bacteriophages. It develops phage treatments of bacterial infections. The company was founded by Jerome Gabard and Manuel Gea in December 2006 and is headquartered in Romainville, France. | Health Technology |
PathoQuest SAS
PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | Health Technology |
